Comparison of VanEck's BBH and State Street's XPH Healthcare ETFs

This analysis compares two healthcare-focused ETFs: VanEck's BBH, which targets 25 large-cap biotech companies, and State Street's XPH, which offers broader exposure with 62 pharmaceutical holdings. Both ETFs have the same annual fee of 0.35%, but their five-year returns have shown significant differences. The comparison highlights the varying investment strategies within the healthcare sector.

Originally published by gnews